Characterization of potential probionts from blue swimming crab Portunus pelagicus and its antagonistic activity against Vibrio harveyi

The aim of this study was to isolate local bacteria as potential probiont in controlling the growth of pathogenic Vibrio harveyi. Eleven potential bacteria were successfully isolated from the haemolymph of four healthy Portunus pelagicus. All of the isolates were identified as Bacillus amyloliquefac...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Abdul Rahman, Noor Azrin, Esa, Yuzine, Md Yasin, Ina Salwany, R., Suzana, Masduki, Nur Fathiah, Abd Karim, Murni Marlina
Materyal Türü: Makale
Dil:English
Baskı/Yayın Bilgisi: International Network for Natural Sciences 2017
Online Erişim:http://psasir.upm.edu.my/id/eprint/61099/1/Characterization%20of%20potential%20probionts%20from%20blue%20swimming%20crab%20Portunus%20pelagicus%20and%20its%20antagonistic%20activity%20against%20Vibrio%20harveyi.pdf
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
Diğer Bilgiler
Özet:The aim of this study was to isolate local bacteria as potential probiont in controlling the growth of pathogenic Vibrio harveyi. Eleven potential bacteria were successfully isolated from the haemolymph of four healthy Portunus pelagicus. All of the isolates were identified as Bacillus amyloliquefaciens by series of biochemical test using triple sugar ion test, oxidase and catalase test, followed by Internal Transcribe Spacer (ITS) gene sequence analysis. This isolate was able to inhibit the growth of V. harveyi in in-vitro screening assay by using well diffusion assay with the strong antagonistic activity from 7 to 16 mm. The potential strains at 108 CFU/ml showed highest inhibition response towards V. harveyi after co-cultured for 48 hr. The isolates produced four major extracellular enzymes which were amylase, protease, gelatinase and lipase and able to form biofilm after 24 hr of cultured. Thus, B. amyloliquefaciens showed important characteristics as probiotic which worth to be carried out for in vivo challenge assay.